Treatment discontinuation and rate of disease transmission in psoriasis patients receiving biologic therapy during the COVID-19 pandemic: A Canadian multicenter retrospective study

J Am Acad Dermatol. 2020 Oct;83(4):1212-1214. doi: 10.1016/j.jaad.2020.07.021. Epub 2020 Jul 15.

¹ Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
² Department of Dermatology, McMaster University, Hamilton, Ontario, Canada; Dermatrials Research Inc & Venderm Innovations in Psoriasis, Hamilton, Ontario, Canada.
³ Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada; Women's College Hospital, Toronto, Ontario, Canada; Probity Medical Research Inc, Waterloo, Ontario, Canada. Electronic address: [email protected].

No abstract available

Publication types